Is the "P-value" Alone a Sufficient Metric for the Magnitude of Clinical Benefit and Which Clinical Trial Is Actually Positive, KEYNOTE-394 or KEYNOTE-240?

This commentary asks if, when determining the target P-value in a clinical study, it is sufficient to evaluate the study as "negative" or "positive" based on the target P-value alone, or whether this could lead to illusions.